8-K/A

FORM 8-K AMENDMENT

Company: Phio Pharmaceuticals Corp.
Filed: December 6, 2019
Period of Report: November 12, 2019
Accession Number: 0001683168-19-003908

View Document ↗ View on SEC.gov ↗